Breast Cancer

Physical therapists Leslie Waltke and Beth Rothman talk about the benefits of rehabilitation and exercise during and after breast cancer treatment.

Updates from the 2008 annual meeting of the American Society of Clinical Oncology includes news on lung, breast, colorectal, and kidney cancers.

What the latest research shows about chemobrain after breast cancer therapy.

Three women share the uncertainty of living with metastatic breast cancer.

Clifford Hudis, MD, talks about HER2-positive breast cancer and the options for treating it.

Women with metastatic breast cancer gather for a phone support group once a week and others seek out retreats and online support services.

A young woman balances motherhood, career, and metastatic breast cancer.

Dr. Len answers the question: “Does discontinuing hormone replacement therapy increase risk of breast cancer?”

Cancer researchers are testing a variety of new treatments for patients with metastatic breast cancer.

A new approach to radiation treatment in early-stage breast cancer employs a larger dose on a shorter schedule.

The FDA approves Avastin for breast cancer and a lung cancer trial involving Nexavar shows no survival benefit.

Who needs treatment after breast cancer surgery?

Risk varies for BRCA carriers.

Breast cancer risk tool updated for African-Americans.

Fighting colon cancer was only part of the battle; this survivor then had to learn how, and what, to eat all over again.

News updates from the American Society of Hematology and the San Antonio Breast Cancer Symposium.

Proactive strategy has patients taking preventive steps to protect their bones during therapy.

Side effect may predict response to treatment.

Why aren't more women having breast reconstruction?

Recent drug approvals yield a new chemotherapy agent, a first for liver cancer, a safer prevention method, and good news for a drug-resistant cancer.

The number of women choosing aggressive breast cancer surgery has doubled in the past decade.

Gary Zollinger's legacy lives on through early detection research.

The timing of post-mastectomy reconstruction can be impacted by many factors.

Are breast cancer rates dropping because of the HRT decline, or are other factors at work?

A number of diagnostic, prognostic, or predictive tests can help determine the optimal course of treatment by using predictive markers from the patient’s or tumor’s genetic information.